Build Back Better

Build Back Better

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccination

Another IgG4 paper.

Mathew Aldred's avatar
Mathew Aldred
Oct 25, 2023
∙ Paid
9
1
Share

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Mathew Aldred
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture